Market Cap 2.98B
Revenue (ttm) 491.73M
Net Income (ttm) 163.89M
EPS (ttm) N/A
PE Ratio 9.53
Forward PE 10.20
Profit Margin 33.33%
Debt to Equity Ratio 0.00
Volume 513,400
Avg Vol 1,324,022
Day's Range N/A - N/A
Shares Out 122.91M
Stochastic %K 72%
Beta 0.69
Analysts Strong Sell
Price Target $34.50

Company Profile

Catalyst Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing medicines for patients living with rare diseases in the United States. It offers Firdapse for the treatment of patients with lambert-eaton myasthenic syndrome (LEMS); Fycompa, a novel non-competitive selective antagonist at the postsynaptic ionotropic alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid glutamate receptor that is used to treat focal onset seizures, as well...

Industry: Biotechnology
Sector: Healthcare
Phone: 305 420 3200
Address:
355 Alhambra Circle, Suite 801, Coral Gables, United States
111ggg
111ggg Dec. 24 at 2:47 PM
$CPRX How about that TVTX!! Hope some of you got in in the twentys. Merry Christmas
0 · Reply
Doozio
Doozio Dec. 23 at 8:45 PM
$CPRX list of STOKs da 🧠 is ready TTWO spread on the DLO ENTA 🐒🍌🧠⏰♾️
0 · Reply
LeRoyRektlord
LeRoyRektlord Dec. 22 at 10:23 PM
0 · Reply
Johnny_Lever
Johnny_Lever Dec. 22 at 6:06 PM
$CPRX Stair stepping higher!
0 · Reply
111ggg
111ggg Dec. 22 at 5:19 PM
$CPRX Is this stock finally out of garbage status? Slowly making higher range top. Should see 23.60 when selloff begins later today.
0 · Reply
WB_Bull
WB_Bull Dec. 22 at 11:13 AM
$CPRX next year could be great! 1. firdapse royality paying is ending january 26 (~ 7-10% = 35 mio) 2. strong growth of agamree 3. Pursue synergistic assets that align with growth strateg (cash 700 mio) 4. maybe patent litigation with hetero will be over 5. Advance the SUMMIT Study to demonstrate AGAMREE’s potential benefits over other DMD treatments 6. FIRDAPSE: Unlocking the Next Phase of Growth in Cancer Associated (“CA”)-LEMS my target for next year $40-50 GLTA
0 · Reply
Calinda
Calinda Dec. 22 at 7:09 AM
$CPRX 👍🏻 FYI: Not a lawyer, but an obsessive fact checker 😎 Posted Friday afternoon on the docket and quite a big deal for Catalyst- 220 order Order Fri 12/19 1:09 PM “TEXT ORDER: n light of the parties' representation at ECF219 that Defendant "Hetero is dropping its indefinite positions on the patents-in-suit," a decision on the parties' Markman positions is moot and will not be rendered by the Court. So Ordered by Judge Michael E. Farbiarz on 12/19/2025. (ro,) “ (219 was the joint status letter by email ordered due 12/17 by the Judge) Patent indefiniteness is a critical issue that can undermine the strength and enforceability of a patent… Hetero withdrew that claim. This seems to have been Hetero’s perceived smoking gun going up in smoke. IMHO a settlement is on the horizon. GL to all!
1 · Reply
StillWaiting101
StillWaiting101 Dec. 19 at 8:56 PM
$CPRX XBI is up 3% on the day
1 · Reply
PrivateProfiteersAnalyst
PrivateProfiteersAnalyst Dec. 19 at 5:41 PM
Actionable Trade Alert for $CPRX: Market Context: $CPRX is currently trading at $23.67, showing a stable position within its recent range. The RSI at 52.66 indicates a neutral sentiment, suggesting potential for upward movement. The stock is above the 30-day moving average (MA30) of $23.00 and significantly above the 50-day moving average (MA50) of $22.19, indicating bullish momentum. Directional Bias: The price is closer to the 60-day high of $25.14, suggesting potential for a breakout. The ATR of $0.73 indicates moderate volatility, allowing for reasonable price movement. Trade Plan: - Suggested Entry: $23.70 - Stop Loss: $22.80 (3.8% risk) - Take Profit Targets: 1. TP1: $24.50 (3.4% gain) 2. TP2: $25.00 (5.0% gain) 3. TP3: $27.75 (17.5% gain) This plan offers a solid risk-reward ratio with a minimum of 17% ROI on TP3. Monitor closely for market conditions. https://privateprofiteers.com
0 · Reply
Hognose
Hognose Dec. 19 at 2:40 PM
$CPRX undervalued and awesome chart
0 · Reply
Latest News on CPRX
Strong Inflows Make Catalyst Stock an Outlier

Jun 11, 2025, 7:08 AM EDT - 7 months ago

Strong Inflows Make Catalyst Stock an Outlier


Strong Revenue, Drug Performance Lift Catalyst Shares

Mar 26, 2025, 8:12 AM EDT - 9 months ago

Strong Revenue, Drug Performance Lift Catalyst Shares


Catalyst Remains a Big Money Favorite

Feb 7, 2025, 3:56 PM EST - 11 months ago

Catalyst Remains a Big Money Favorite


111ggg
111ggg Dec. 24 at 2:47 PM
$CPRX How about that TVTX!! Hope some of you got in in the twentys. Merry Christmas
0 · Reply
Doozio
Doozio Dec. 23 at 8:45 PM
$CPRX list of STOKs da 🧠 is ready TTWO spread on the DLO ENTA 🐒🍌🧠⏰♾️
0 · Reply
LeRoyRektlord
LeRoyRektlord Dec. 22 at 10:23 PM
0 · Reply
Johnny_Lever
Johnny_Lever Dec. 22 at 6:06 PM
$CPRX Stair stepping higher!
0 · Reply
111ggg
111ggg Dec. 22 at 5:19 PM
$CPRX Is this stock finally out of garbage status? Slowly making higher range top. Should see 23.60 when selloff begins later today.
0 · Reply
WB_Bull
WB_Bull Dec. 22 at 11:13 AM
$CPRX next year could be great! 1. firdapse royality paying is ending january 26 (~ 7-10% = 35 mio) 2. strong growth of agamree 3. Pursue synergistic assets that align with growth strateg (cash 700 mio) 4. maybe patent litigation with hetero will be over 5. Advance the SUMMIT Study to demonstrate AGAMREE’s potential benefits over other DMD treatments 6. FIRDAPSE: Unlocking the Next Phase of Growth in Cancer Associated (“CA”)-LEMS my target for next year $40-50 GLTA
0 · Reply
Calinda
Calinda Dec. 22 at 7:09 AM
$CPRX 👍🏻 FYI: Not a lawyer, but an obsessive fact checker 😎 Posted Friday afternoon on the docket and quite a big deal for Catalyst- 220 order Order Fri 12/19 1:09 PM “TEXT ORDER: n light of the parties' representation at ECF219 that Defendant "Hetero is dropping its indefinite positions on the patents-in-suit," a decision on the parties' Markman positions is moot and will not be rendered by the Court. So Ordered by Judge Michael E. Farbiarz on 12/19/2025. (ro,) “ (219 was the joint status letter by email ordered due 12/17 by the Judge) Patent indefiniteness is a critical issue that can undermine the strength and enforceability of a patent… Hetero withdrew that claim. This seems to have been Hetero’s perceived smoking gun going up in smoke. IMHO a settlement is on the horizon. GL to all!
1 · Reply
StillWaiting101
StillWaiting101 Dec. 19 at 8:56 PM
$CPRX XBI is up 3% on the day
1 · Reply
PrivateProfiteersAnalyst
PrivateProfiteersAnalyst Dec. 19 at 5:41 PM
Actionable Trade Alert for $CPRX: Market Context: $CPRX is currently trading at $23.67, showing a stable position within its recent range. The RSI at 52.66 indicates a neutral sentiment, suggesting potential for upward movement. The stock is above the 30-day moving average (MA30) of $23.00 and significantly above the 50-day moving average (MA50) of $22.19, indicating bullish momentum. Directional Bias: The price is closer to the 60-day high of $25.14, suggesting potential for a breakout. The ATR of $0.73 indicates moderate volatility, allowing for reasonable price movement. Trade Plan: - Suggested Entry: $23.70 - Stop Loss: $22.80 (3.8% risk) - Take Profit Targets: 1. TP1: $24.50 (3.4% gain) 2. TP2: $25.00 (5.0% gain) 3. TP3: $27.75 (17.5% gain) This plan offers a solid risk-reward ratio with a minimum of 17% ROI on TP3. Monitor closely for market conditions. https://privateprofiteers.com
0 · Reply
Hognose
Hognose Dec. 19 at 2:40 PM
$CPRX undervalued and awesome chart
0 · Reply
Hognose
Hognose Dec. 19 at 2:39 PM
$FOLD I called Fold, next $CPRX $ABCL $ASND
0 · Reply
ShortsHater
ShortsHater Dec. 19 at 1:01 AM
0 · Reply
111ggg
111ggg Dec. 18 at 8:16 PM
$CPRX political pressure on high drug costs which now includes possibly OTCing many drugs may be factor.
0 · Reply
NakedDayTrader4
NakedDayTrader4 Dec. 18 at 5:49 PM
$CPRX I don’t get this stock. I was in it back in February, after finding it in one of my stock screens. The fundamentals are just off the charts, I got out of the markets in April and just got back in mid November and this stock has done nothing and still has great fundamentals. Mystery to me. Is this just universally hated or does Wall Street have it in the penalty box for some reason?
1 · Reply
StillWaiting101
StillWaiting101 Dec. 18 at 3:07 PM
$CPRX pretty light volume for 2% down after we had big volume on the way up
0 · Reply
111ggg
111ggg Dec. 18 at 2:47 PM
$CPRX Back to bottom of range. If you want to bet with 10 shares for $1.X gain, buy now but sell at top of range.
0 · Reply
PrivateProfiteersAnalyst
PrivateProfiteersAnalyst Dec. 17 at 4:26 AM
Actionable Trade Alert for $CPRX: Market Context: $CPRX is currently trading at $24.19, showing a strong upward momentum with an RSI of 56.61, indicating bullish sentiment. The stock has recently tested the 60D high of $25.14, suggesting potential for further gains. Directional Bias: The stock's price is above both the 30-day MA (22.83) and the 50-day MA (22.06), reinforcing a bullish outlook. The RSI indicates strength without being overbought, allowing room for upward movement. Trade Plan: - Suggested Entry: $24.20 - Stop Loss: $23.00 (approximately 5% below entry) - Take Profit Targets: - TP1: $25.00 (3.3% gain) - TP2: $25.50 (5.4% gain) - TP3: $28.40 (17.5% gain) With a potential ROI of over 17% at TP3, this trade offers a favorable risk-reward ratio. Monitor closely for any changes in momentum. https://privateprofiteers.com
0 · Reply
111ggg
111ggg Dec. 16 at 10:04 PM
$CPRX Nice day for TVTX. Wish I could say that for the rest of my portfolio.
1 · Reply
111ggg
111ggg Dec. 16 at 10:02 PM
$CPRX Normal day end action. If I was in a casino, I would play 24 on the roulette wheel.
0 · Reply
Viking0919
Viking0919 Dec. 16 at 3:34 AM
0 · Reply
Viking0919
Viking0919 Dec. 16 at 3:00 AM
0 · Reply
beachlife
beachlife Dec. 15 at 8:19 PM
$CPRX And to think I almost sold at 22 from a strong sell recommendation ;)
1 · Reply